06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today announced that they have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals, Inc ... About Madrigal Pharmaceuticals.
22, 2026 (GLOBE NEWSWIRE) -- MadrigalPharmaceuticals, Inc ... The equity awards were approved by Madrigal's independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4) ... About Madrigal Pharmaceuticals ... Madrigal Pharmaceuticals Inc.